ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Liabilities
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Other Noncurrent Liabilities of $21.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $21.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $1.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$462.00K, a 425.35% decline from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $142.00K, a 59.89% decline from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $354.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $21.00K 10-Q · filed 2026-08-12 | $21.00K derived: sum of 3 quarters · filed 2026-08-12 | $21.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | -$109.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | -$109.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$109.00K derived: sum of 2 quarters · filed 2026-08-12 | $1.00K 10-Q · filed 2025-11-12 | -$461.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.00K 10-Q · filed 2026-08-12 | -$461.00K derived: sum of 3 quarters · filed 2026-08-12 | -$461.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $110.00K 10-Q · filed 2026-05-12 | -$352.00K derived: sum of 2 quarters · filed 2026-05-12 | -$352.00K derived: sum of 3 quarters · filed 2026-05-12 | -$352.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$462.00K derived: sum of 2 quarters · filed 2026-03-16 | -$462.00K derived: sum of 3 quarters · filed 2026-03-16 | -$462.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $34.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $34.00K derived: sum of 3 quarters · filed 2025-05-15 | $244.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $34.00K derived: sum of 2 quarters · filed 2025-03-07 | $244.00K derived: sum of 3 quarters · filed 2025-03-07 | $142.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $244.00K derived: sum of 2 quarters · filed 2024-11-12 | $142.00K 10-Q · filed 2024-11-12 | $252.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $108.00K 10-Q · filed 2024-08-12 | $218.00K derived: sum of 3 quarters · filed 2024-08-12 | $320.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$102.00K 10-Q · filed 2024-05-09 | $8.00K derived: sum of 2 quarters · filed 2024-05-09 | $110.00K derived: sum of 3 quarters · filed 2024-05-09 | $154.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $212.00K derived: sum of 2 quarters · filed 2024-03-28 | $256.00K derived: sum of 3 quarters · filed 2024-03-28 | $354.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $146.00K derived: sum of 2 quarters · filed 2023-11-01 | $244.00K 10-Q · filed 2023-11-01 | -$466.00K derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $142.00K 10-Q · filed 2023-08-08 | -$568.00K derived: sum of 3 quarters · filed 2023-08-08 | -$117.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $98.00K 10-Q · filed 2023-05-08 | -$612.00K derived: sum of 2 quarters · filed 2023-05-08 | -$161.00K derived: sum of 3 quarters · filed 2023-05-08 | -$411.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | -$259.00K derived: sum of 2 quarters · filed 2023-02-08 | -$509.00K derived: sum of 3 quarters · filed 2023-02-08 | -$509.00K 10-K · filed 2023-02-08 |
| 2021-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $201.00K derived: sum of 2 quarters · filed 2022-11-08 | $201.00K 10-Q · filed 2022-11-08 | -$125.00K derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$250.00K 10-Q · filed 2022-08-08 | -$576.00K derived: sum of 3 quarters · filed 2023-02-08 | -$13.00K derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | -$326.00K derived: sum of 2 quarters · filed 2023-02-08 | $237.00K derived: sum of 3 quarters · filed 2023-02-08 | |
| 2020-12-31 | -$326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $237.00K derived: sum of 2 quarters · filed 2023-02-08 | $778.00K 10-K · filed 2023-02-08 | |
| 2020-09-30 | $563.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.10M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $541.00K 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $280.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $280.00K derived: sum of 3 quarters · filed 2021-03-01 | $306.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $280.00K derived: sum of 2 quarters · filed 2021-03-01 | $306.00K derived: sum of 3 quarters · filed 2021-03-01 | $319.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $306.00K derived: sum of 2 quarters · filed 2021-03-01 | $319.00K derived: sum of 3 quarters · filed 2021-03-01 | $372.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $39.00K derived: sum of 2 quarters · filed 2019-11-07 | $92.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $66.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $53.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $407.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |